Nu Skin Enterprises, Inc. (NYSE:NUS – Get Rating) Chairman Steven Lund sold 21,200 shares of the company’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of $45.25, for a total value of $959,300.00. Following the completion of the transaction, the chairman now directly owns 180,374 shares in the company, valued at approximately $8,161,923.50. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Steven Lund also recently made the following trade(s):
- On Wednesday, May 18th, Steven Lund sold 925 shares of Nu Skin Enterprises stock. The shares were sold at an average price of $46.07, for a total value of $42,614.75.
NYSE:NUS traded down $1.80 during mid-day trading on Wednesday, reaching $45.34. 452,351 shares of the stock were exchanged, compared to its average volume of 728,620. The company has a 50 day simple moving average of $46.68 and a 200-day simple moving average of $47.92. The stock has a market capitalization of $2.28 billion, a P/E ratio of 16.93 and a beta of 1.24. The company has a quick ratio of 0.95, a current ratio of 1.72 and a debt-to-equity ratio of 0.28. Nu Skin Enterprises, Inc. has a 1 year low of $39.40 and a 1 year high of $62.70.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 8th. Shareholders of record on Friday, May 27th will be given a dividend of $0.385 per share. The ex-dividend date is Thursday, May 26th. This represents a $1.54 dividend on an annualized basis and a yield of 3.40%. Nu Skin Enterprises’s payout ratio is 57.04%.
Several research firms recently issued reports on NUS. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price on the stock in a research note on Tuesday, March 29th. Jefferies Financial Group increased their target price on Nu Skin Enterprises from $61.00 to $75.00 in a research note on Thursday, February 17th. StockNews.com lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Friday, May 13th. TheStreet downgraded Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. Finally, DA Davidson upped their price target on Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a “neutral” rating in a report on Thursday, February 17th. Three analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $60.60.
A number of institutional investors have recently bought and sold shares of NUS. State Street Corp lifted its position in Nu Skin Enterprises by 317.6% during the 1st quarter. State Street Corp now owns 6,520,579 shares of the company’s stock worth $312,205,000 after acquiring an additional 4,959,089 shares during the period. Millennium Management LLC lifted its holdings in shares of Nu Skin Enterprises by 1,050.2% in the 4th quarter. Millennium Management LLC now owns 703,938 shares of the company’s stock valued at $35,725,000 after buying an additional 642,738 shares during the period. Norges Bank acquired a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $23,843,000. Cooper Creek Partners Management LLC acquired a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at approximately $23,609,000. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Nu Skin Enterprises by 423.3% in the 4th quarter. The Manufacturers Life Insurance Company now owns 430,185 shares of the company’s stock valued at $21,832,000 after buying an additional 347,985 shares during the period. 93.79% of the stock is owned by institutional investors.
Nu Skin Enterprises Company Profile (Get Rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
- Get a free copy of the StockNews.com research report on Nu Skin Enterprises (NUS)
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Dynatrace: Fundamentals are Positive While Being Punished
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
- Now’s The Time To Buy Disney (NYSE: DIS)
- 3 Small Caps With Big Return Potential
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.